ZIELGERICHTETE THERAPEUTIKA

European patent · EP3129064 · Deleted

Register entry

Publication number
EP3129064
Application number
EP15758717
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Mar 3, 2015
Published
Feb 15, 2017
Granted
Jan 1, 2020
Deleted
Mar 31, 2020
Reason
Annual fee unpaid
IPC classes
A61K 47/50 (2017.01)
Priority
US 201461947108 P 03.03.2014
PCT application
PCT/US2015/018442 03.03.2015
PCT publication
WO2015/134464 11.09.2015
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 21, 2020

    Deleted, fee unpaid

    Published in Swissreg on 21.10.2020

  2. Jan 1, 2020

    Granted

    Published in Swissreg on 01.01.2020

Parties

Holder

Madrigal Pharmaceuticals, Inc.

Four Tower Bridge 200 Barr Harbor Drive, Suite 400, West Conshohocken, Pennsylvania 19428, US

Inventor

CHIMMANAMADA, Dinesh, U.

Arlington, MA 02474, US

YING, Weiwen

Lexington MA 02421, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.